Cargando…

Formulation Strategies of Nanosuspensions for Various Administration Routes

Nanosuspensions (NSs), which are nanosized colloidal particle systems, have recently become one of the most interesting substances in nanopharmaceuticals. NSs have high commercial potential because they provide the enhanced solubility and dissolution of low-water-soluble drugs by means of their smal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pınar, Sıla Gülbağ, Oktay, Ayşe Nur, Karaküçük, Alptuğ Eren, Çelebi, Nevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221665/
https://www.ncbi.nlm.nih.gov/pubmed/37242763
http://dx.doi.org/10.3390/pharmaceutics15051520
_version_ 1785049510552010752
author Pınar, Sıla Gülbağ
Oktay, Ayşe Nur
Karaküçük, Alptuğ Eren
Çelebi, Nevin
author_facet Pınar, Sıla Gülbağ
Oktay, Ayşe Nur
Karaküçük, Alptuğ Eren
Çelebi, Nevin
author_sort Pınar, Sıla Gülbağ
collection PubMed
description Nanosuspensions (NSs), which are nanosized colloidal particle systems, have recently become one of the most interesting substances in nanopharmaceuticals. NSs have high commercial potential because they provide the enhanced solubility and dissolution of low-water-soluble drugs by means of their small particle sizes and large surface areas. In addition, they can alter the pharmacokinetics of the drug and, thus, improve its efficacy and safety. These advantages can be used to enhance the bioavailability of poorly soluble drugs in oral, dermal, parenteral, pulmonary, ocular, or nasal routes for systemic or local effects. Although NSs often consist mainly of pure drugs in aqueous media, they can also contain stabilizers, organic solvents, surfactants, co-surfactants, cryoprotectants, osmogents, and other components. The selection of stabilizer types, such as surfactants or/and polymers, and their ratio are the most critical factors in NS formulations. NSs can be prepared both with top-down methods (wet milling, dry milling, high-pressure homogenization, and co-grinding) and with bottom-up methods (anti-solvent precipitation, liquid emulsion, and sono-precipitation) by research laboratories and pharmaceutical professionals. Nowadays, techniques combining these two technologies are also frequently encountered. NSs can be presented to patients in liquid dosage forms, or post-production processes (freeze drying, spray drying, or spray freezing) can also be applied to transform the liquid state into the solid state for the preparation of different dosage forms such as powders, pellets, tablets, capsules, films, or gels. Thus, in the development of NS formulations, the components/amounts, preparation methods, process parameters/levels, administration routes, and dosage forms must be defined. Moreover, those factors that are the most effective for the intended use should be determined and optimized. This review discusses the effect of the formulation and process parameters on the properties of NSs and highlights the recent advances, novel strategies, and practical considerations relevant to the application of NSs to various administration routes.
format Online
Article
Text
id pubmed-10221665
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102216652023-05-28 Formulation Strategies of Nanosuspensions for Various Administration Routes Pınar, Sıla Gülbağ Oktay, Ayşe Nur Karaküçük, Alptuğ Eren Çelebi, Nevin Pharmaceutics Review Nanosuspensions (NSs), which are nanosized colloidal particle systems, have recently become one of the most interesting substances in nanopharmaceuticals. NSs have high commercial potential because they provide the enhanced solubility and dissolution of low-water-soluble drugs by means of their small particle sizes and large surface areas. In addition, they can alter the pharmacokinetics of the drug and, thus, improve its efficacy and safety. These advantages can be used to enhance the bioavailability of poorly soluble drugs in oral, dermal, parenteral, pulmonary, ocular, or nasal routes for systemic or local effects. Although NSs often consist mainly of pure drugs in aqueous media, they can also contain stabilizers, organic solvents, surfactants, co-surfactants, cryoprotectants, osmogents, and other components. The selection of stabilizer types, such as surfactants or/and polymers, and their ratio are the most critical factors in NS formulations. NSs can be prepared both with top-down methods (wet milling, dry milling, high-pressure homogenization, and co-grinding) and with bottom-up methods (anti-solvent precipitation, liquid emulsion, and sono-precipitation) by research laboratories and pharmaceutical professionals. Nowadays, techniques combining these two technologies are also frequently encountered. NSs can be presented to patients in liquid dosage forms, or post-production processes (freeze drying, spray drying, or spray freezing) can also be applied to transform the liquid state into the solid state for the preparation of different dosage forms such as powders, pellets, tablets, capsules, films, or gels. Thus, in the development of NS formulations, the components/amounts, preparation methods, process parameters/levels, administration routes, and dosage forms must be defined. Moreover, those factors that are the most effective for the intended use should be determined and optimized. This review discusses the effect of the formulation and process parameters on the properties of NSs and highlights the recent advances, novel strategies, and practical considerations relevant to the application of NSs to various administration routes. MDPI 2023-05-17 /pmc/articles/PMC10221665/ /pubmed/37242763 http://dx.doi.org/10.3390/pharmaceutics15051520 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pınar, Sıla Gülbağ
Oktay, Ayşe Nur
Karaküçük, Alptuğ Eren
Çelebi, Nevin
Formulation Strategies of Nanosuspensions for Various Administration Routes
title Formulation Strategies of Nanosuspensions for Various Administration Routes
title_full Formulation Strategies of Nanosuspensions for Various Administration Routes
title_fullStr Formulation Strategies of Nanosuspensions for Various Administration Routes
title_full_unstemmed Formulation Strategies of Nanosuspensions for Various Administration Routes
title_short Formulation Strategies of Nanosuspensions for Various Administration Routes
title_sort formulation strategies of nanosuspensions for various administration routes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221665/
https://www.ncbi.nlm.nih.gov/pubmed/37242763
http://dx.doi.org/10.3390/pharmaceutics15051520
work_keys_str_mv AT pınarsılagulbag formulationstrategiesofnanosuspensionsforvariousadministrationroutes
AT oktayaysenur formulationstrategiesofnanosuspensionsforvariousadministrationroutes
AT karakucukalptugeren formulationstrategiesofnanosuspensionsforvariousadministrationroutes
AT celebinevin formulationstrategiesofnanosuspensionsforvariousadministrationroutes